Our Portfolio
Our companies are developing innovative therapeutics for severe diseases and contitions. We are backing great teams with development programs that make a true difference for patients.
Alentis Therapeutics
AlentisTherapeutics discovers and develops novel mediacations to treat advanced liver diseases, such as liver fibrosis, cirrhosis and liver cancer (hepatocellular carcinoma, HCC).
Website
AM Pharma
AM-Pharma is a clinical stage biopharmaceutical company developing recombinant human Alkaline Phosphatase (recAP) as a potentially life-saving treatment of acute kidney injury and sepsis.
Website
Araris Biotech
Araris Biotech is a spin-off from the PSI / ETH Zurich developing next generation antibody-drug conjugates for the treatment of different cancers.
Website
BaseLaunch
BaseLaunch is the Basel area-based incubator and accelerator that helps scientists and entrepreneurs to launch exceptional biotech companies in Switzerland.
Website
Corlieve Therapeutics
Corlieve Therapeutics is a French biotech company, developing transformational therapies for neurological diseases. The lead program is a treatment for drug resistant temporal lobe epilepsy leveraging innovative gene therapy approaches.
Website
Eyevensys
Eyevensys is a clinical-stage ophthalmology biotech company developing non-viral gene therapies for severe eye diseases using its ocular electro-transfection platform technology.
Website
ImCheck Therapeutics
ImCheck Therapeutics is developing novel antibody therapeutics that target butyrophilin checkpoint molecules to activate immune cells for the treatment of cancer.
Website
Lava Therapeutics
Lava Therapeutics is developing bi- specific gamma- delta T-cell engagers for the treatment of hematological and solid cancers.
Website
NovaGo Therapeutics
NovaGo Therapeutics is a Swiss start-up dedicated to the development of regenerative therapies for diseases in the eye and the central nervous system.
Website
Vico Therapeutics
Vico Therapeutics is a Dutch biotech company developing anti-sense oligonucleotides for treating rare severe neurological disorders with high unmet medical need.
Website